Corteria Pharmaceuticals Alternatives & Competitors
12 companies similar to Corteria Pharmaceuticals — Interceptive therapies for the treatment of heart failure subpopulations
Companies similar to Corteria Pharmaceuticals
Ultragenyx
Going Beyond Every Day
Novato, United States
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Skye Bioscience Inc.
Unlocking new therapeutic pathways for metabolic health
San Diego, United States
Rival Readout
Competing with Corteria Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Heartseed Inc.
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...
Japan
Seagen
A global biotechnology company dedicated to developing revolutionary therapies with real i...
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
Kynexis
Kynexis is advancing the first potential precision medicine for the treatment of CIAS.
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
THRASOS LIMITED
Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
About Corteria Pharmaceuticals
Corteria Pharmaceuticals, founded in 2021, is a France-based biotechnology company focused on developing transformative interceptive therapies specifically tailored for treating subpopulations experiencing worsening and acute decompensated heart failure. Situated at the intersection of the Biotechnology, Health and Wel...
Development of first-in-class drugs, Targeted therapies for high unmet medical needs, Clinical trial management, Patient stratification methodology
Patients with heart failure, Patients with sarcopenia, Patients with obesity and related complications, Healthcare providers
Heart Failure Treatment, Pharmaceutical Development, First-in-class Drugs, Subpopulation Targeting, Transformative Therapies, Worsening Heart Failure, Acute Decompensated Heart Failure
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Corteria Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Corteria Pharmaceuticals on 7 Jun 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
